SUZANNE OPARIL, University of Alabama, Birmingham
REFERENCE: Abstract 405-12, American College of Cardiolgy New Orleans
A combination of two antihypertensive agents has given improved blood pressure control in a study with nearly 2000 patients reported to the ACC meeting in New Orleans by a group from the University of Alabama at Birmingham. Suzanne Oparil presented findings on the use of the direct rennin inhibitor, aliskiren, combined with the angiotensin receptor blocker, valsartan. She explained to Peter Goodwin how this “dual renin system blockade” gave enhanced blood pressure lowering in patients with mild to moderate hypertension who were followed with ambulatory monitoring.
A combination of two antihypertensive agents has given improved blood pressure control in a study with nearly 2000 patients reported to the ACC meeting in New Orleans by a group from the University of Alabama at Birmingham. Suzanne Oparil presented findings on the use of the direct rennin inhibitor, aliskiren, combined with the angiotensin receptor blocker, valsartan. She explained to Peter Goodwin how this “dual renin system blockade” gave enhanced blood pressure lowering in patients with mild to moderate hypertension who were followed with ambulatory monitoring.
Audio clip: Adobe Flash Player (version 9 or above) is required to play this audio clip. Download the latest version here. You also need to have JavaScript enabled in your browser.